SCD

Austin, Texas, August 20, 2026 Raintree Systems has expanded its agentic artificial intelligence (AI) platform for rehabilitation therapy, introducing...

Summit, New Jersey, August 20, 2026 Vascarta Inc. has announced the initiation of a Phase I clinical study of...

CAMBRIDGE, Mass., June 13, 2026 Agios Pharmaceuticals, Inc. announced detailed results from the 52-week double-blind portion of the global...

BOSTON, June 11, 2026 Vertex Pharmaceuticals announced new Phase 3 clinical data demonstrating the potential of CASGEVY® (exagamglogene autotemcel)...

CAMBRIDGE, Mass., June 1, 2026 Fulcrum Therapeutics announced the discontinuation of its lead investigational therapy pociredir for the treatment...